The high court will decide the availability of mifepristone, a widely used abortion pill, by agreeing on Wednesday to hear the Biden administration's appeal of a ruling that would bar the drug's mail-order prescriptions.

The Biden administration asked the high court on Sept. 8 to uphold broad access to mifepristone, the widely used abortion pill, seeking a review of a ruling that would bar mail-order prescriptions and require in-person doctor visits.

The latest emergency decision to cancel $6 billion in student debt relief is unrelated to Biden's broader effort, which the high court is expected to rule on in June.

After months of legal challenges, the high court heard arguments yesterday on Pres. Biden's $10,000 student loan relief program and seems poised to reject, but will make its final decision by the end of June.

The high court is being asked to lift a federal appeals court order in October that shut down the program, which has already approved 16 million debt forgiveness applications.

The ruling "consigns women to second-class citizenship," dissenting judges wrote. A majority of the U.S. public has supported keeping abortion legal.

U.S. Bancorp urged the court to reject the appeal, saying Congress didn't intend for plans to face litigation when participants haven't been hurt.

The former employee of Intel had access to electronic documents describing the investments -- but he says he doesn't recall reading them.